Australis Capital (CSE:AUSA) announced an agreement to acquire all shares of Rthm Technologies.
As quoted in the press release:
As a privately held, federally incorporated company, Rthm holds several brand-associated trademarks and has developed the world’s first mobile genetics and circadian rhythm mapping platform for both iOS and Android devices.
Among the most advanced digital health platforms in the world, Rthm has developed a complete suite of proprietary technology including advanced heart rate tracking and analysis algorithms and comprehensive circadian rhythm mapping techniques. Built and designed to support every customer in achieving their unique health and wellness needs, Rthm is a top ranked health app with millions of downloads worldwide.
“Rthm is exceptionally positioned to leverage its proprietary biometric technologies to develop the world’s most advanced cannabis curation, delivery, and loyalty platform,” said Scott Dowty, Chief Executive Officer of Australis Capital.